Fragment-based computational design of antibodies targeting structured epitopes

Area of Science:

• Biochemistry
• Computational Biology
• Immunology

Background:

• Antibody discovery is time-consuming and expensive.
• Targeting specific epitopes precisely is challenging.
• De novo design offers a promising alternative.

Purpose of the Study:

• To develop a fragment-based computational method for de novo antibody design.
• To create stable, high-affinity antibodies targeting predetermined epitopes.
• To assess the method's efficiency using SARS-CoV-2 spike protein as a target.

Main Methods:

• Combinatorial design of antibody binding loops.
• Grafting designed loops onto antibody scaffolds.
• Testing designs against multiple antigens, including SARS-CoV-2 spike protein.
• Biophysical characterization of antibody stability and binding affinity.

Main Results:

• Successfully designed and tested six single-domain antibodies.
• All designs exhibited stability and nanomolar binding affinities.
• No in vitro affinity maturation was required.
• Method works with both crystal structures and computer-generated models.

Conclusions:

• The fragment-based de novo design method accelerates antibody generation.
• Precise epitope targeting is achievable computationally.
• This approach reduces time and cost in antibody discovery.
• The method is robust, requiring only moderate-resolution antigen structures.